Company ORIC Pharmaceuticals, Inc. Börse Stuttgart
Equities
4TZ
US68622P1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 EUR | -1.41% | +6.77% | -12.88% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 06/05/18 |
Richard Heyman
FOU | Founder | 66 | 31/12/13 |
Director of Finance/CFO | 50 | 31/08/19 | |
Lori Friedman
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/06/19 |
Edna Maneval
CTO | Chief Tech/Sci/R&D Officer | 64 | 28/02/19 |
Pratik Multani
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/08/18 |
Dan Iazzetti
HRO | Human Resources Officer | - | 31/08/22 |
Matthew Panuwat
PRN | Corporate Officer/Principal | 47 | 31/10/18 |
General Counsel | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 08/11/21 |
Richard Heyman
FOU | Founder | 66 | 31/12/13 |
Mardi Dier
BRD | Director/Board Member | 60 | 01/03/20 |
Lori Kunkel
BRD | Director/Board Member | 66 | 08/06/20 |
Jacob Chacko
CEO | Chief Executive Officer | 45 | 06/05/18 |
Steven Hoerter
BRD | Director/Board Member | 53 | 12/08/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,422,307 | 60,981,029 ( 90.45 %) | 0 | 90.45 % |
Company contact information
Oric Pharmaceuticals, Inc.
240 East Grand Avenue 2nd Floor
94080, South San Francisco
+650 388 5600
http://www.oricpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- ORIC Stock
- 4TZ Stock
- Company ORIC Pharmaceuticals, Inc.